Endogenous Angiotensin II Induces Atherosclerotic Plaque Vulnerability and Elicits a Th1 Response in ApoE −/− Mice
- 1 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 44 (3) , 277-282
- https://doi.org/10.1161/01.hyp.0000140269.55873.7b
Abstract
Rupture of vulnerable plaques is the main cause of acute cardiovascular events. However, mechanisms responsible for transforming a stable into a vulnerable plaque remain elusive. Angiotensin II, a key regulator of blood pressure homeostasis, has a potential role in atherosclerosis. To study the contribution of angiotensin II in plaque vulnerability, we generated hypertensive hypercholesterolemic ApoE−/− mice with either normal or endogenously increased angiotensin II production (renovascular hypertension models). Hypertensive high angiotensin II ApoE−/− mice developed unstable plaques, whereas in hypertensive normal angiotensin II ApoE−/− mice plaques showed a stable phenotype. Vulnerable plaques from high angiotensin II ApoE−/− mice had thinner fibrous cap (P<0.01), larger lipid core (P<0.01), and increased macrophage content (P<0.01) than even more hypertensive but normal angiotensin II ApoE−/− mice. Moreover, in mice with high angiotensin II, a skewed T helper type 1-like phenotype was observed. Spleno...Keywords
This publication has 18 references indexed in Scilit:
- From Vulnerable Plaque to Vulnerable PatientCirculation, 2003
- Induction of a Regulatory T Cell Type 1 Response Reduces the Development of Atherosclerosis in Apolipoprotein E–Knockout MiceCirculation, 2003
- Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient miceJournal of Clinical Investigation, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque ruptureJournal of the American College of Cardiology, 1994
- Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.Heart, 1993
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992
- Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1990
- Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal VolunteersJournal of Cardiovascular Pharmacology, 1987
- A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.The Journal of cell biology, 1986